European regulatory aspects of phage therapy: magistral phage preparations

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

(2021) Michael Schlander et al.   PHARMACOECONOMICS

Bacteriophages: it's a medicine, Jim, but not as we know it

(2020) Jean-Paul Pirnay et al.   LANCET INFECTIOUS DISEASES

Phage Therapy: Towards a Successful Clinical Trial

(2020) Andrzej Górski et al.   Antibiotics-Basel

Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified

(2019) Sarah Djebara et al.   Viruses-Basel

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

(2019) Rebekah M. Dedrick et al.   NATURE MEDICINE

The Magistral Phage

(2018) Jean-Paul Pirnay et al.   Viruses-Basel

A Systematic and Critical Review of Bacteriophage Therapy against Multi-Drug Resistant ESKAPE Organisms in Humans

(2018) Lynn El Haddad et al.   CLINICAL INFECTIOUS DISEASES

Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution withPseudomonas aeruginosacystic fibrosis bacterial isolates

(2015) V-P. Friman et al.   JOURNAL OF EVOLUTIONARY BIOLOGY

Call for a Dedicated European Legal Framework for Bacteriophage Therapy

(2014) Gilbert Verbeken et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS